BELLUS Health Inc. (BLU)
NASDAQ: BLU
· Real-Time Price · USD
14.74
0.00 (0.00%)
At close: Jun 28, 2023, 9:59 PM
BELLUS Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.65B | 1.52B | 3K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Cost of Revenue | 1.61B | 1.45B | 1.43B | 920.39M | 923.92M | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 41.4M | 75.77M | -1.43B | -920.38M | -923.92M | 4K | 4K | 4K | 4K | 4K | 4K |
Operating Income | -66.51M | -39.5M | -27.72M | -21.67M | -23.07M | -17.84M | -15.3M | -16.5M | -22.87M | -18M | -15.91M |
Interest Income | 2.24M | 2.1M | 3.13M | 2.53M | 1.86M | 400K | 296K | 52K | 47K | 63K | 71K |
Pretax Income | -41.12M | -20.83M | -25.04M | -18.23M | -24.73M | -18.73M | -14.33M | -14.96M | -22.88M | -17.83M | -15.75M |
Net Income | -42.7M | -22.19M | -25.06M | -18.25M | -24.71M | -18.78M | -14.35M | -14.76M | -22.88M | -17.83M | -15.75M |
Selling & General & Admin | 100.7M | 107.96M | 5.39M | 4.23M | 5.84M | 5.38M | 4.05M | 4.17M | 3.82M | 2.81M | 3.47M |
Research & Development | n/a | n/a | 22.41M | 17.56M | 17.35M | 12.6M | 11.38M | 12.55M | 19.26M | 15.39M | 12.59M |
Other Expenses | n/a | n/a | -73K | -112K | -113K | -140K | -126K | n/a | n/a | n/a | n/a |
Operating Expenses | 80.27M | 94.49M | 27.73M | 21.68M | 23.08M | 17.84M | 15.3M | 16.5M | 22.88M | 18.01M | 15.92M |
Interest Expense | n/a | n/a | 20K | 23K | 26K | 15K | 14K | 11K | 10K | 8K | 26K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.69B | 1.54B | 27.73M | 21.68M | 23.08M | 17.84M | 15.3M | 16.5M | 22.88M | 18.01M | 15.92M |
Income Tax Expense | 1.64M | 1.42M | 19K | 19K | -25K | 41K | 25K | -188K | 10K | 8K | 26K |
Shares Outstanding (Basic) | 392.95M | 410.34M | 126.58M | 115.36M | 121.8M | 106.76M | 106.49M | 78.83M | 78.34M | 78.34M | 78.34M |
Shares Outstanding (Diluted) | 405.79M | 410.34M | 126.58M | 115.36M | 121.8M | 106.76M | 106.49M | 78.83M | 78.34M | 78.34M | 78.34M |
EPS (Basic) | -0.11 | -0.05 | -0.2 | -0.16 | -0.2 | -0.18 | -0.13 | -0.19 | -0.29 | -0.23 | -0.2 |
EPS (Diluted) | -0.11 | -0.05 | -0.2 | -0.16 | -0.2 | -0.18 | -0.13 | -0.19 | -0.29 | -0.23 | -0.2 |
EBITDA | -59.3M | -32.2M | -25.01M | -19.06M | -21.14M | -17.36M | -15.2M | -16.39M | -22.78M | -17.89M | -15.8M |
EBIT | -66.51M | -39.5M | -25.02M | -18.2M | -24.7M | -18.72M | -14.31M | -14.99M | -22.91M | -17.88M | -15.77M |
Depreciation & Amortization | 7.21M | 7.31M | 2.72M | 2.62M | 1.93M | 472K | 100K | 57K | 45K | 46K | 45K |